Want to join the conversation?
$SYK 1Q15 10-Q: Research, development and engineering expenses increased 1.3% to $152MM in 2015 or 6.4% of net sales compared to 6.5% in 2014. The increased spending levels in 2015 were driven by the timing of projects and Stryker’s continued investment in new technologies. SG&A expenses were 37.5% of net sales in 2015 vs. 37.3% in 2014.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?